BeiGene, Ltd. 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-28 6:58 pm Purchase | 2021-09-24 | 13D | Leap Therapeutics, Inc. LPTX | BeOne Medicines Ltd. ONC | 1,215,307 13.200% | 254,380 (+26.47%) | Filing |